Weiyu Peng

Shenzhen, 518000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Analysis of Epidemiological and Evolutionary Characteristics of Seasonal Influenza Viruses in Shenzhen City from 2018 to 2024.

Analysis of Epidemiological and Evolutionary Characteristics of Seasonal Influenza Viruses in Shenzhen City from 2018 to 2024.

Journal: Viruses

Published: March 23, 2025

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12-2023.4 wave of the COVID-19 pandemic.

Clinical characteristics and antibody response to Omicron variants among solid carcinoma patients in China on the 2022.12-2023.4 wave of the COVID-19 pandemic.

Journal: Frontiers in immunology

Published: August 14, 2024

Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.

Precise motif and cross-presentation of coronavirus peptides by feline MHC class I: implications for the mild infection of SARS-CoV-2.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: March 13, 2024

Characterization of CD8+ T cells in immune-privileged organs of ZIKV-infected Ifnar1-/- mice.

Characterization of CD8+ T cells in immune-privileged organs of ZIKV-infected Ifnar1-/- mice.

Journal: Journal of virology

Published: January 03, 2024

Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.

Defining a de novo non-RBM antibody as RBD-8 and its synergistic rescue of immune-evaded antibodies to neutralize Omicron SARS-CoV-2.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 18, 2023

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants.

Evaluation of cross-neutralizing antibodies in children infected with omicron sub-variants.

Journal: The Lancet regional health. Western Pacific

Published: August 21, 2023

Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.

Structural and inhibitor sensitivity analysis of influenza B-like viral neuraminidases derived from Asiatic toad and spiny eel.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: October 03, 2022

The CD8+ and CD4+ T Cell Immunogen Atlas of Zika Virus Reveals E, NS1 and NS4 Proteins as the Vaccine Targets.

The CD8+ and CD4+ T Cell Immunogen Atlas of Zika Virus Reveals E, NS1 and NS4 Proteins as the Vaccine Targets.

Journal: Viruses

Published: September 21, 2022

Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.

Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.

Journal: Small science

Published: August 09, 2022

A Wider and Deeper Peptide-Binding Groove for the Class I Molecules from B15 Compared with B19 Chickens Correlates with Relative Resistance to Marek's Disease.

A Wider and Deeper Peptide-Binding Groove for the Class I Molecules from B15 Compared with B19 Chickens Correlates with Relative Resistance to Marek's Disease.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: April 06, 2022

Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.

Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.

Journal: Small science

Published: December 03, 2021

An engineered bispecific human monoclonal antibody against SARS-CoV-2.

An engineered bispecific human monoclonal antibody against SARS-CoV-2.

Journal: Nature immunology

Published: September 05, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026